The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Novartis (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
Role of time to switch from ipilimumab to anti-PD1 in anti-PD1 efficacy within the French national cohort, MelBase.
 
Clara Allayous
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb
 
Stéphane Dalle
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Marie Thérèse Leccia
No Relationships to Disclose
 
Francois Aubin
Honoraria - Abbvie; Celgene; LEO Pharma; Merck Sharp & Dohme; Novartis
Consulting or Advisory Role - Celgene; Janssen; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Abbvie; Janssen; Merck Sharp & Dohme; Novartis
 
Laurent Mortier
No Relationships to Disclose
 
Marie- Beylot-Barry
Consulting or Advisory Role - Roche
 
Philippe Saiag
Honoraria - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Sophie Dalac-Rat
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck Sharp & Dohme; Roche
 
Jean Philippe Lacour
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
 
Eve Maubec
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme
Research Funding - Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Vincent Descamps
No Relationships to Disclose
 
Bernard Guillot
No Relationships to Disclose
 
Thierry Lesimple
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Roche
 
Julie De Quatrebarbes
No Relationships to Disclose
 
Jean-Philippe Arnault
No Relationships to Disclose
 
Pierre-Emmanuel Stoebner
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Abbvie; Janssen-Cilag; Novartis
 
Raphael Porcher
No Relationships to Disclose
 
Alice Ballon
No Relationships to Disclose
 
Bastien Oriano
No Relationships to Disclose
 
Celeste Lebbe
Honoraria - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche